188 related articles for article (PubMed ID: 20518849)
21. Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility.
Snook JH; Li J; Helmke BP; Guilford WH
Free Radic Biol Med; 2008 Jan; 44(1):14-23. PubMed ID: 18045543
[TBL] [Abstract][Full Text] [Related]
22. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury.
Wang P; Zweier JL
J Biol Chem; 1996 Nov; 271(46):29223-30. PubMed ID: 8910581
[TBL] [Abstract][Full Text] [Related]
23. Glutathione reverses peroxynitrite-mediated deleterious effects of nitroglycerin on ischemic rat hearts.
Fan Q; Yang XC; Cao XB; Wang SY; Yang SL; Liu XL; Gao F
J Cardiovasc Pharmacol; 2006 Mar; 47(3):405-12. PubMed ID: 16633083
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and peroxynitrite in postischemic myocardium.
Zweier JL; Fertmann J; Wei G
Antioxid Redox Signal; 2001 Feb; 3(1):11-22. PubMed ID: 11294189
[TBL] [Abstract][Full Text] [Related]
25. Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria.
Yang M; Xu Y; Heisner JS; Sun J; Stowe DF; Kwok WM; Camara AKS
Mitochondrion; 2019 May; 46():380-392. PubMed ID: 30391711
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
[TBL] [Abstract][Full Text] [Related]
27. A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model.
Lauzier B; Sicard P; Bouchot O; Delemasure S; Moreau D; Vergely C; Rochette L
Fundam Clin Pharmacol; 2007 Apr; 21(2):173-80. PubMed ID: 17391290
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation.
Wang HC; Zhang HF; Guo WY; Su H; Zhang KR; Li QX; Yan W; Ma XL; Lopez BL; Christopher TA; Gao F
Apoptosis; 2006 Aug; 11(8):1453-60. PubMed ID: 16761110
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
[TBL] [Abstract][Full Text] [Related]
30. Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury.
Krzywonos-Zawadzka A; Franczak A; Olejnik A; Radomski M; Gilmer JF; Sawicki G; Woźniak M; Bil-Lula I
J Cell Mol Med; 2019 Apr; 23(4):2836-2848. PubMed ID: 30729745
[TBL] [Abstract][Full Text] [Related]
31. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
32. Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes.
Yu XW; Liu MY; Kennedy RH; Liu SJ
J Physiol; 2005 Jul; 566(Pt 2):341-53. PubMed ID: 15878941
[TBL] [Abstract][Full Text] [Related]
33. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
Roczkowsky A; Chan BYH; Lee TYT; Mahmud Z; Hartley B; Julien O; Armanious G; Young HS; Schulz R
Cardiovasc Res; 2020 Apr; 116(5):1021-1031. PubMed ID: 31373602
[TBL] [Abstract][Full Text] [Related]
34. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes.
Soloviev A; Stefanov A; Parshikov A; Khromov A; Moibenko A; Kvotchina L; Balavoine G; Geletii Y
Cardiovasc Toxicol; 2002; 2(2):129-39. PubMed ID: 12271156
[TBL] [Abstract][Full Text] [Related]
35. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione.
Viappiani S; Nicolescu AC; Holt A; Sawicki G; Crawford BD; León H; van Mulligen T; Schulz R
Biochem Pharmacol; 2009 Mar; 77(5):826-34. PubMed ID: 19046943
[TBL] [Abstract][Full Text] [Related]
36. The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death.
Klassen SS; Rabkin SW
Naunyn Schmiedebergs Arch Pharmacol; 2009 Feb; 379(2):149-61. PubMed ID: 18773197
[TBL] [Abstract][Full Text] [Related]
37. Peroxynitrite decomposition catalyst prevents matrix metalloproteinase-9 activation and neurovascular injury after hemoglobin injection into the caudate nucleus of rats.
Ding R; Feng L; He L; Chen Y; Wen P; Fu Z; Lin C; Yang S; Deng X; Zeng J; Sun G
Neuroscience; 2015 Jun; 297():182-93. PubMed ID: 25849612
[TBL] [Abstract][Full Text] [Related]
38. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Bencsik P; Kupai K; Giricz Z; Görbe A; Pipis J; Murlasits Z; Kocsis GF; Varga-Orvos Z; Puskás LG; Csonka C; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H512-8. PubMed ID: 20543091
[TBL] [Abstract][Full Text] [Related]
39. Synergistic protection of MLC 1 against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future.
Cadete VJ; Arcand SA; Lin HB; Sawicki G
Future Med Chem; 2013 Mar; 5(4):389-98. PubMed ID: 23495687
[TBL] [Abstract][Full Text] [Related]
40. Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling.
Chen H; Guan B; Wang B; Pu H; Bai X; Chen X; Liu J; Li C; Qiu J; Yang D; Liu K; Wang Q; Qi S; Shen J
Transl Stroke Res; 2020 Oct; 11(5):967-982. PubMed ID: 31872339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
